3

PRIMARY DOCUMENT

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: September 11, 2020
Period of Report: September 1, 2020
Accession Number: 0001076809-20-000154

View Document ↗ View on SEC.gov ↗